Delivery Order SPE2DB22D3501-SPE2DB26FTL69
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50 count) with a firm fixed price ceiling value of $2,669.48. This non-set-aside competitive award is scheduled for completion by August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $1,557.76 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ramelteon 8 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 23, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ramelteon 8 mg tablets (100-count units) with a contract ceiling value of $3,606.44. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The ultimate completion date is August 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,147.26 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (50-unit dose packaging) on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,431.92 for Ramelteon 8 mg tablets (30-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA. This...
- This delivery order, valued at $2,751.58, was awarded on September 8, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count packages). The contract represents a non-competitive, firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $2,039.56 to AmerisourceBergen Drug Corp for 30 tablets of Ramelteon 8 mg, a medication used to treat insomnia. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.54 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (30-count supply) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ramelteon is a prescription sleep aid medication used in the treatment of insomnia, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50-count) with a contract ceiling value of $7,347.27. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The ultimate completion date is set for September 26, 2025, and the product will be delivered to AmerisourceBergen's location in Conshohocken,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,511.45 contract is for the provision of 30-count tablets of the pharmaceutical drug Ramelteon 8 mg. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards from DLA...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTL69Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,465.53 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets in unit dose packaging (50-count) with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price contract utilized no set-aside designation and represents a direct delivery order fulfillment for pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, a $999.9 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the supply of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The IDC represents a prime vendor arrangement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen Drug Corp as a critical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/10/25 |